Catheter

SonoVascular Enters into Strategic Collaboration with Lantheus Holdings, Inc. for Use of Microbubbles in Combination with SonoThrombectomy™ System for Treatment of Venous Thromboembolism

Retrieved on: 
Thursday, May 2, 2024
Safety, VTE, FIH, Partnership, Pulmonary embolism, Patient, DVT, Catheter, Microbubble, Vein, Coronary thrombosis, Deep vein thrombosis

VTE is a condition that occurs when a blood clot forms in a deep vein, resulting in DVT.

Key Points: 
  • VTE is a condition that occurs when a blood clot forms in a deep vein, resulting in DVT.
  • The microbubbles are activated by intravascular ultrasound and will be investigated in ongoing pre-clinical and upcoming clinical studies.
  • The SonoThrombectomy System has been engineered to address and overcome the deficiencies and limitations of current interventional devices.
  • Additionally, upon completion of a FIH study, SonoVascular has an option to enter into a long-term exclusive commercial supply agreement with Lantheus.

EQS-News: Volta Medical Announces Late-Breaking TAILORED-AF Randomized Clinical Trial Results at Heart Rhythm 2024 in Boston, MA, USA

Retrieved on: 
Friday, May 3, 2024
Atrial fibrillation, Loyola University Medical Center, Ecosystem, AI, Poster, Heart, Machine learning, Artificial intelligence, Artificiality, Communication, Environment, Data collection, PVI, Arrhythmia, Collection, Rhythm, Clinical trial, Electrophysiology, Catheter, Northwell Health, Medical device

This AI companion technology may help electrophysiologists to optimize catheter-ablation procedures for complex arrhythmias, including persistent AF.

Key Points: 
  • This AI companion technology may help electrophysiologists to optimize catheter-ablation procedures for complex arrhythmias, including persistent AF.
  • Professor Isabel Deisenhofer will share findings from the TAILORED-AF clinical trial.
  • Volta Medical is hosting a Rhythm Theater presentation, “The Future of AI Implementation in AF Ablation Procedures”.
  • Volta Medical will exhibit at booth #328, featuring a demonstration of the Volta AF-Xplorer™ software, while a tech suite at #TS266 will spotlight the company’s product vision.

Using clinical-led AI, Truveta expands clinical notes and medical images available to advance research

Retrieved on: 
Thursday, May 2, 2024
Migraine, Roger Hawkins (drummer), Metadata, Hospital, Cardiology, Nuclear medicine, EHR, MD, Research, Pathology, Hypercholesterolemia, Seizure, Cancer, Disease, Exercise, NASH, Documentation, Patient, Diet, Medicine, MRI, Health, Catheter, Algorithm, Cardiac catheterization, Heart failure, Medical imaging

By providing a complete view of the patient journey, Truveta enables researchers to accelerate therapy adoption, improve clinical trials and enhance patient care.

Key Points: 
  • By providing a complete view of the patient journey, Truveta enables researchers to accelerate therapy adoption, improve clinical trials and enhance patient care.
  • Using the most advanced, award-winning AI technology , Truveta extracts the data from these notes and cleans it to enable research.
  • Medical images are updated daily, cleaned with clinical expert-led AI, and de-identified with industry-leading privacy and security technology.
  • Images can be analyzed in notebooks in Truveta Studio and included in studies for scientifically rigorous research.

Elixir Medical To Announce Data from Three Platforms Designed to Transform Cardiovascular Disease Treatment at EuroPCR 2024, Including Two Late-Breakers

Retrieved on: 
Tuesday, April 30, 2024
Research, Medical Devices, Clinical Trials, Health Technology, Cardiology, Biotechnology, Health, General Health, Science, Elixir, Hospital, Coronary artery disease, Safety, PINNACLE, Catheterization laboratory, MD, Trial of the century, Doctor of Philosophy, PCI, TRX, OCT, CAD, Medicine, DES, Standard of care, Paulo, RCT, Plaque, MACE, Skåne University Hospital, Catheter, Pharmaceutical industry

“There remains a large unmet need for transformative technology in cardiovascular intervention to address limitations of coronary artery disease (CAD) treatments such as maintaining the established artery flow lumen, restoring vessel hemodynamic modulation, and stabilizing or regressing plaque to deliver durable and incremental clinical benefit.

Key Points: 
  • “There remains a large unmet need for transformative technology in cardiovascular intervention to address limitations of coronary artery disease (CAD) treatments such as maintaining the established artery flow lumen, restoring vessel hemodynamic modulation, and stabilizing or regressing plaque to deliver durable and incremental clinical benefit.
  • In the absence of restoring artery function, today we see 20% MACE within 5 years1 and 50% by 10 years2 after PCI attributable to non-plateauing annual adverse events with DES,”3 said Motasim Sirhan, CEO of Elixir Medical.
  • Featured as an Innovation Session presentation, the clinical results are intended to demonstrate safety and efficacy of Elixir’s lithotripsy technology designed to simplify treatment of a broad range of complex calcified lesions while advancing safety and efficacy of calcium modification.
  • Additionally, Elixir Medical will share late-breaking 12-month outcomes of its TRx site-specific antithrombotic therapeutic from the DESyne BDS Plus RCT, a prospective, multicenter, single-blind study evaluating the safety, effectiveness, and performance of the world’s first triple-drug site-specific antithrombotic therapy (TRx) on a DES compared to DESyne X2 Drug-Eluting Coronary Stent System in the treatment of de novo native coronary artery lesions.

Global Airway Management Devices Market Analysis and Forecast, 2023-2033: Competitive Landscape, Ecosystem, Reimbursement Scenario, Patent Analysis, Partnerships, Collaborations, & Business Expansions - ResearchAndMarkets.com

Retrieved on: 
Monday, April 29, 2024
General Health, Health, Medical Devices, Chronic obstructive pulmonary disease, Airway management, Competitive landscape, Catheter, Anesthesia, Asthma, Growth, Prevalence, COPD, Airline

North America is poised to emerge as a major contributor to the growth of the airway management devices market.

Key Points: 
  • North America is poised to emerge as a major contributor to the growth of the airway management devices market.
  • What are the major market drivers, challenges and opportunities in the global airway management devices market and their case studies?
  • What is the market share of the leading segments and sub-segments of the global airway management devices market?
  • How will each segment of the global airway management devices market grow during the forecast period?

Medical Adhesives & Sealants World Market Report 2024: Remineralizing Agents Being Used to Restore Resin-Based Dental Materials - ResearchAndMarkets.com

Retrieved on: 
Monday, April 22, 2024
Medical Supplies, Health, Internal, Acrylic, Catheter, Polyurethane, Instrument, Metal, Dental, Fibrin, Cosmetics, Skin, Dentistry, USB On-The-Go, Medical device, Polymer, Suture, Plastic surgery, Adhesive, Surgical instrument, Equipment

The "Medical Adhesives & Sealants World Market Report" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Adhesives & Sealants World Market Report" has been added to ResearchAndMarkets.com's offering.
  • There are several applications for adhesives and sealants the medical sector, including in the areas of dentistry & cosmetics, internal & external surgery and medical devices & equipment.
  • Among these, acrylic, silicone, polyurethane, polyethylene glycol and cyanoacrylate are most widely used materials to make synthetic/semi-synthetic adhesives & sealants.
  • This world market compendium analyzes the market for Medical Adhesives & Sealants at a high level by resin type/sub-type, application, end-use sector and geographic region.

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte™ Image Guided Crossing and Re-Entry Catheter System

Retrieved on: 
Thursday, April 11, 2024
Medical Devices, FDA, Health, Health Technology, Radiology, Cardiology, Operational technology, Catheter, American College, Coronary artery disease, Food, MD, Angioplasty, Interventions, OCT, Patient, Diagnosis, Plaque, Journal, Medical imaging

Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

Key Points: 
  • Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
  • The Acolyte Image Guided Crossing and Re-Entry Catheter System aims to overcome these challenges by providing clinicians with this breakthrough device that has enhanced visualization and navigation capabilities, ultimately improving CTO crossing, procedural success rates, and patient outcomes.
  • "We are thrilled to receive FDA's Breakthrough Device Designation for our Acolyte Image Guided Crossing and Re-Entry Catheter System," said Dr. John B. Simpson, PhD, MD, Founder and CEO of Simpson Interventions.
  • Simpson Interventions is committed to collaborating closely with the FDA and other stakeholders to advance the development and regulatory review of the Acolyte Image Guided Crossing and Re-Entry Catheter System.

Physicians and Military Medics In Ukraine Receive Free Point Of Care Ultrasound Training From Global Ultrasound Institute (GUSI)

Retrieved on: 
Tuesday, April 23, 2024
GUSI, Learning, FOCUS, Pneumothorax, Survival, Trauma, Triage, FAST, Extremities, Freedom, Amputation, Science, Patient, Catheter, Physician, POCUS, Internal bleeding, Health, Student, SAN, Refugee, Nursing

Within these stringent parameters, the POCUS Essentials Course—offered at no cost by Global Ultrasound Institute (GUSI)—has proved to be invaluable.

Key Points: 
  • Within these stringent parameters, the POCUS Essentials Course—offered at no cost by Global Ultrasound Institute (GUSI)—has proved to be invaluable.
  • The video curriculum, closed-captioned in Ukrainian, is led by experts in point of care ultrasound.
  • As part of the FOCUS POCUS ultrasound team, Dr. Vus and other Ukrainian physicians have led free training for the military, refugees, and students.
  • "Thanks to Global Ultrasound Institute, more than 3,000 doctors and military medics have been trained in this life-saving technology," he said.

Polyimide Coating Market Size to Grow USD 2.2 Billion by 2031 at a CAGR of 6.7% | Valuates Reports

Retrieved on: 
Monday, April 22, 2024
USD, Catheter, Safety, Electricity, Fluid mechanics, Semiconductor, Life, Patient safety, Electronics, Telecommunications, Electronic, Longevity, Endoscopy, Printed circuit board

BANGALORE, India, April 22, 2024 /PRNewswire/ -- Polyimide Coating Market By Type (Thermoset, Thermoplastic), By Application (Electronic parts, Tubing, Electrical insulation, Fiber optic cables, Others)

Key Points: 
  • BANGALORE, India, April 22, 2024 /PRNewswire/ -- Polyimide Coating Market By Type (Thermoset, Thermoplastic), By Application (Electronic parts, Tubing, Electrical insulation, Fiber optic cables, Others)
    The Global Polyimide Coating Market size was valued at USD 1.2 Billion in 2021, and is projected to reach USD 2.2 Billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.
  • The market for polyimide coatings is expanding rapidly due to its vital applications in a wide range of sectors.
  • The electronics manufacturing industry, where polyimide coatings are essential for safeguarding electronic components, is a major driver of the market's growth.
  • The market for polyimide coating is driven by this application as the need for stronger and more lasting aerospace materials is expanding.

Polyimide Coating Market Size to Grow USD 2.2 Billion by 2031 at a CAGR of 6.7% | Valuates Reports

Retrieved on: 
Monday, April 22, 2024
USD, Catheter, Safety, Electricity, Fluid mechanics, Semiconductor, Life, Patient safety, Electronics, Telecommunications, Electronic, Longevity, Endoscopy, Printed circuit board

BANGALORE, India, April 22, 2024 /PRNewswire/ -- Polyimide Coating Market By Type (Thermoset, Thermoplastic), By Application (Electronic parts, Tubing, Electrical insulation, Fiber optic cables, Others)

Key Points: 
  • BANGALORE, India, April 22, 2024 /PRNewswire/ -- Polyimide Coating Market By Type (Thermoset, Thermoplastic), By Application (Electronic parts, Tubing, Electrical insulation, Fiber optic cables, Others)
    The Global Polyimide Coating Market size was valued at USD 1.2 Billion in 2021, and is projected to reach USD 2.2 Billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.
  • The market for polyimide coatings is expanding rapidly due to its vital applications in a wide range of sectors.
  • The electronics manufacturing industry, where polyimide coatings are essential for safeguarding electronic components, is a major driver of the market's growth.
  • The market for polyimide coating is driven by this application as the need for stronger and more lasting aerospace materials is expanding.